ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,317,000 | -25.3% | 58,600 | 0.0% | 0.29% | -25.3% |
| Q4 2017 | $1,764,000 | -20.1% | 58,600 | 0.0% | 0.39% | -24.7% |
| Q3 2017 | $2,207,000 | +35.1% | 58,600 | 0.0% | 0.52% | +26.0% |
| Q2 2017 | $1,634,000 | +117.0% | 58,600 | +167.6% | 0.41% | +91.6% |
| Q1 2017 | $753,000 | +81.4% | 21,900 | +52.1% | 0.22% | +48.3% |
| Q4 2016 | $415,000 | -9.4% | 14,400 | 0.0% | 0.14% | -12.7% |
| Q3 2016 | $458,000 | -1.9% | 14,400 | 0.0% | 0.17% | -6.2% |
| Q2 2016 | $467,000 | +15.9% | 14,400 | 0.0% | 0.18% | +30.1% |
| Q1 2016 | $403,000 | -21.4% | 14,400 | 0.0% | 0.14% | -24.9% |
| Q4 2015 | $513,000 | – | 14,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |